Reveal Surgical

Company overview

Reveal Surgical is a Montréal medical device developer focused on real-time tissue characterization during cancer surgery. Formerly ODS Medical, it is affiliated with Reveal Life Science, the group's molecular-sensing and artificial-intelligence research platform.

Its Sentry platform combines optical probes, Raman spectroscopy and machine-learning software to provide molecular information about tissue. Current programs address brain-tumor surgery and ex-vivo assessment of breast-surgery specimens.

The company’s surgical technologies remain investigational. Reveal Life Science also describes NaviSense, an endoscopic tissue-guidance development program.

^{[1][2][3][5][6][7]}

Products & regulatory status How does MedTechIndex get this information?

Summary

Sentry Precision and Sentry Scanner are investigational technologies. The company describes a PMA development pathway for Sentry Precision. ^[5][6]

Regulatory snapshot How to read this snapshot

U.S. FDA

—

510(k) clearances

—

De Novo grants

—

PMA approvals

—

Recall events

Latest recorded source review: 2026-11-02.

Scope: selected product families.

Commercial portfolio snapshot

No commercially marketed product portfolio has been established in the reviewed material.

Commercial development

Sentry surgical tissue-characterization platform ↗

Investigational Raman-spectroscopy and AI platform for intraoperative tissue assessment. Sentry Precision targets brain-tumor resection, while Sentry Scanner is being developed for ex-vivo assessment of excised breast tissue margins. ^[2][5]

Investigational / not commercially available

Investigational / not commercially available